N. Androulakis

1.6k total citations
46 papers, 1.3k citations indexed

About

N. Androulakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, N. Androulakis has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in N. Androulakis's work include Cancer Treatment and Pharmacology (24 papers), Colorectal Cancer Treatments and Studies (16 papers) and Lung Cancer Treatments and Mutations (15 papers). N. Androulakis is often cited by papers focused on Cancer Treatment and Pharmacology (24 papers), Colorectal Cancer Treatments and Studies (16 papers) and Lung Cancer Treatments and Mutations (15 papers). N. Androulakis collaborates with scholars based in Greece, United States and Kuwait. N. Androulakis's co-authors include Kostas Kalbakis, John Souglakos, S. Kakolyris, Sofia Agelaki, Vassilis Georgoulias, Vassilis Georgoulias, Charalambos Kouroussis, N. Vardakis, C. Kourousis and Stylianos Kakolyris and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

N. Androulakis

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Androulakis Greece	20	1.1k	681	290	236	182	46	1.3k
Ch. Kouroussis Greece	23	1.4k 1.2×	621 0.9×	392 1.4×	275 1.2×	187 1.0×	54	1.6k
B. Mirtsching United States	12	1.1k 1.0×	459 0.7×	288 1.0×	182 0.8×	131 0.7×	27	1.3k
Aris Polyzos Greece	19	1.2k 1.1×	607 0.9×	262 0.9×	229 1.0×	267 1.5×	55	1.5k
D. Quietzsch Germany	14	886 0.8×	461 0.7×	291 1.0×	135 0.6×	210 1.2×	30	1.1k
Nikolaos Ziras Greece	17	996 0.9×	369 0.5×	304 1.0×	150 0.6×	207 1.1×	55	1.2k
A. Kalykaki Greece	16	934 0.8×	387 0.6×	329 1.1×	218 0.9×	126 0.7×	52	1.2k
Federica Cuppone Italy	20	1.1k 1.0×	604 0.9×	388 1.3×	199 0.8×	111 0.6×	50	1.5k
Ralph Wong Canada	5	1.3k 1.1×	400 0.6×	325 1.1×	209 0.9×	220 1.2×	8	1.5k
Nina Karaseva Russia	12	948 0.8×	759 1.1×	156 0.5×	339 1.4×	86 0.5×	20	1.3k
Alfredo Romano Spain	12	842 0.7×	280 0.4×	346 1.2×	144 0.6×	189 1.0×	19	1.0k

Countries citing papers authored by N. Androulakis

Since Specialization

Citations

This map shows the geographic impact of N. Androulakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Androulakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Androulakis more than expected).

Fields of papers citing papers by N. Androulakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Androulakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Androulakis. The network helps show where N. Androulakis may publish in the future.

Co-authorship network of co-authors of N. Androulakis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Androulakis. A scholar is included among the top collaborators of N. Androulakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Androulakis. N. Androulakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bamias, Aristotle, Stavros D. Peroukidis, Kimon Tzannis, et al.. (2015). Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG). Clinical Genitourinary Cancer. 14(2). e153–e159. 4 indexed citations

Androulakis, N., Sofia Agelaki, Maria Perraki, et al.. (2012). Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer. British Journal of Cancer. 106(12). 1917–1925. 28 indexed citations

Boukovinas, Ioannis, N. Androulakis, L. Vamvakas, et al.. (2006). Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group. Annals of Oncology. 17(11). 1687–1692. 11 indexed citations

Souglakos, John, Konstantinos Syrigos, Anna Potamianou, et al.. (2004). Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial. Annals of Oncology. 15(8). 1204–1209. 41 indexed citations

Kakolyris, Stylianos, John Souglakos, Ch. Kouroussis, et al.. (2004). Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors. Oncology. 66(4). 253–259. 2 indexed citations

Stathopoulos, G., S. Rigatos, Meletios Α. Dimopoulos, et al.. (2003). Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. Annals of Oncology. 14(3). 388–394. 39 indexed citations

Mavroudis, D., Periklis Pappas, Ch. Kouroussis, et al.. (2003). A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors. Annals of Oncology. 14(2). 304–312. 32 indexed citations

Vamvakas, L., S. Kakolyris, Ch. Kouroussis, et al.. (2002). Irinotecan (CPT-11) in Combination With Infusional 5-Fluorouracil and Leucovorin (de Gramont Regimen) as First-Line Treatment in Patients With Advanced Colorectal Cancer. American Journal of Clinical Oncology. 25(1). 65–70. 16 indexed citations

Mavroudis, D., Ch. Kouroussis, S. Kakolyris, et al.. (2002). Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors. Oncology. 62(3). 216–222. 29 indexed citations

10.

Agelaki, Sofia, Charalambos Kouroussis, John Souglakos, et al.. (2001). Vinorelbine-Based Regimens as Salvage Treatment in Patients with Advanced Non-Small Cell Lung Cancer: Two Parallel Multicenter Phase II Trials. Oncology. 60(3). 235–241. 5 indexed citations

11.

Kakolyris, S., Dimitriοs Mavroudis, John Souglakos, et al.. (2001). Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study. Annals of Oncology. 12(2). 193–198. 40 indexed citations

12.

Kouroussis, Charalambos, S. Kakolyris, Dimitris Mavroudis, et al.. (2001). A Dose-Finding Study of the Weekly Administration of Paclitaxel in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology. 24(4). 404–407. 9 indexed citations

13.

Agelaki, Sofia, Charalambos Kouroussis, John Souglakos, et al.. (2001). Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study. Lung Cancer. 34. 77–80. 12 indexed citations

14.

Giannakakis, T., Stylianos Kakolyris, Dimitriοs Mavroudis, et al.. (2000). Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma. European Journal of Cancer. 36(6). 742–747. 11 indexed citations

15.

Mavroudis, Dimitriοs, C. Kourousis, N. Androulakis, et al.. (2000). Frontline Treatment of Advanced Gastric Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor (G-CSF). American Journal of Clinical Oncology. 23(4). 341–344. 82 indexed citations

16.

Kakolyris, S., C. Kourousis, Michael I. Koukourakis, et al.. (1999). First-Line Treatment of Metastatic Breast Cancer With Mitoxantrone, Vinorelbine, and Carboplatin. American Journal of Clinical Oncology. 22(6). 568–568. 5 indexed citations

17.

Georgoulias, Vassilis, N. Androulakis, Demosthenes Bouros, et al.. (1998). nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer. Lung Cancer. 21(3). 213–220. 13 indexed citations

18.

Georgoulias, Vassilis, N. Androulakis, Meletios Α. Dimopoulos, et al.. (1998). First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study. Annals of Oncology. 9(3). 331–334. 65 indexed citations

19.

Androulakis, N., Charalambos Kouroussis, S. Kakolyris, et al.. (1998). Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study. Annals of Oncology. 9(10). 1127–1130. 47 indexed citations

20.

Koukourakis, Michael I., C. Kourousis, Sophia Koukouraki, et al.. (1998). Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial. European Journal of Cancer. 34(6). 838–844. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact